Funding for this research was provided by:
National High Level Hospital Clinical Research Funding (2022-PUMCH-C-058)
Received: 5 August 2022
Accepted: 25 July 2023
First Online: 23 August 2023
: The trial has been ethically approved by the Institutional Review Board (IRB) of Peking Union Medical College Hospital (PUMCH), no: I-23PJ818. Study consent from the patient in each center will be obtained by a fixed oncologist with experience in diagnosis and treatment of gestational trophoblastic neoplasia, who is an associate professor or above. Important modification will be reported to the ethical committees. Upon review, modifications will be registered at Clinical Trials and informed the participants through emails, WeChat and telephone.
: Not applicable.
: The authors declare that they have no competing interests.